AgomAb Therapeutics NV

AGMBNASDAQ
$10.20
-0.01-0.1%
Last update: Sep 28, 5:45 PM

AgomAb Therapeutics Market Sentiment

Market sentiment signals for AgomAb Therapeutics (AGMB): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus— Overweight
Short Interest▲ 2.1% short float
Options Flow— N/A
Insider Activity— N/A

Analyst Consensus

Overweight

7 analysts

Options Flow (P/C)

—

Avg Consensus PT

$38

+267.6%

Highest Price Target

$60

+488.2%

Piper Sandler

Lowest Price Target

$28

+174.5%

Morgan Stanley

Short Interest

2.1%

Declining — Bullish

Insider Activity (30d)

—

Short Interest — % of Float

Recent Analyst Actions

DateFirmAnalyst & AccuracyUpside / DownsidePT ChangeActionRating
Aug 25, 2026Piper Sandler
Yasmeen Rahimi—
+488.2%$60InitiateOverweight
Aug 19, 2026Cantor Fitzgerald
Yanni Souroutzidis—
——InitiateOverweight